Advertisement

FDA Approves Test to Help Diagnose Children's Intellectual Disabilities — Physician’s First Watch

Medical News |
January 21, 2014

FDA Approves Test to Help Diagnose Children's Intellectual Disabilities

By the Editors

The FDA has approved the Affymetrix CytoScan Dx Assay to help detect chromosomal abnormalities in children. This information can be used to help identify causes of intellectual and developmental disabilities.

The assay analyzes a patient's entire genome using a single blood sample and can detect both large and small variations in areas of the genome linked to intellectual and developmental disabilities. In a test of 960 blood samples, the new assay outperformed karyotyping and FISH chromosomal tests in detecting abnormalities.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement